| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | JAMA - Journal of the American Medical Association | 2001 | 21.5K |
| Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | Lancet, The | 2020 | 15K |
| The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report | JAMA - Journal of the American Medical Association | 2003 | 13.6K |
| Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study | American Journal of Preventive Medicine | 1998 | 9K |
| Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology | Journal of the American Society of Echocardiography | 2005 | 9K |
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Circulation | 2005 | 8K |
| Apoptosis: a review of programmed cell death | Toxicologic Pathology | 2007 | 7.7K |
| A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Lancet, The | 2012 | 7.6K |
| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study | Lancet, The | 2004 | 7.5K |
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | New England Journal of Medicine | 2000 | 6.9K |
| Prediction of coronary heart disease using risk factor categories | Circulation | 1998 | 6.8K |
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Lancet, The | 2002 | 6.6K |
| Inflammation, atherosclerosis, and coronary artery disease | New England Journal of Medicine | 2005 | 6.3K |
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | New England Journal of Medicine | 1995 | 6.3K |
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Lancet, The | 1994 | 6.2K |
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | New England Journal of Medicine | 1996 | 6.1K |
| Structure-antioxidant activity relationships of flavonoids and phenolic acids | Free Radical Biology and Medicine | 1996 | 6K |
| Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest | New England Journal of Medicine | 2002 | 6K |
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Lancet, The | 2012 | 5.8K |
| Atrial fibrillation as an independent risk factor for stroke: the Framingham Study | Stroke | 1991 | 5.2K |
| Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction | New England Journal of Medicine | 1998 | 5.2K |
| Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction | New England Journal of Medicine | 2002 | 5.1K |
| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | BMJ: British Medical Journal | 2002 | 4.7K |
| Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study | Journal of the National Cancer Institute | 1998 | 4.6K |
| C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | New England Journal of Medicine | 2000 | 4.6K |
